MarketCap
Facebook
X
Telegram
Land |
 Russische Föderation |
IPO-Jahr |
- |
Branche |
Pharmaeinzelhändler |
Börse |
MOEXSPB |
Anteile |
91.5 M |
Marktkapitalisierung (LTM) |
₽ 739 M |
EBITDA (LTM) |
₽ -28 M |
Kurs/Gewinn, KGV (LTM) |
-10.4 |
Kurs/Umsatz, KUV (LTM) |
1.4 |
Gewinn je Aktie, EPS (LTM) |
₽ -0.8 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Molecular Templates
MTEM
|
- | -23.43 % | $ 495 K | Nasdaq Capital Market |  USA |
 |
Vanda Pharmaceuticals
VNDA
|
$ 3.82 | 6.27 % | $ 225 M | Nasdaq Global Select Market,SPB | USA |
 |
Verrica Pharmaceuticals
VRCA
|
$ 3.22 | 4.21 % | $ 34.3 M | Nasdaq Global Market | USA |
 |
Viridian Therapeutics
VRDN
|
$ 28.47 | -0.28 % | $ 2.9 B | Nasdaq Capital Market | USA |
 |
BioXcel Therapeutics
BTAI
|
$ 0.07 | 9.81 % | $ 855 K | Nasdaq Global Select Market,SPB | USA |
 |
VistaGen Therapeutics
VTGN
|
$ 0.17 | 3.45 % | $ 6.47 M | Nasdaq Global Select Market | USA |
 |
Voyager Therapeutics
VYGR
|
$ 1.86 | 8.14 % | $ 109 M | Nasdaq Global Select Market | USA |
 |
CohBar
CWBR
|
- | -15.44 % | $ 2.2 M | Nasdaq Capital Market | USA |
 |
NeuBase Therapeutics
NBSE
|
- | -1.56 % | $ 12.3 M | Nasdaq Global Select Market | USA |
 |
Gossamer Bio
GOSS
|
$ 9.77 | 3.72 % | $ 2.23 B | Nasdaq Global Select Market,SPB | USA |
 |
Deciphera Pharmaceuticals
DCPH
|
- | - | $ 2.18 B | Nasdaq Global Select Market,SPB | USA |
 |
GeoVax Labs
GOVX
|
$ 0.16 | -5.0 % | $ 153 K | Nasdaq Global Select Market | USA |
 |
Arena Pharmaceuticals
ARNA
|
- | -6.81 % | $ 3.04 B | Nasdaq Global Select Market,SPB | USA |
 |
Scopus BioPharma
SCPS
|
- | -48.37 % | $ 3.71 M | Nasdaq Global Select Market | USA |
 |
Annovis Bio
ANVS
|
$ 0.82 | 23.72 % | $ 16.9 M | NYSE American | USA |
 |
scPharmaceuticals
SCPH
|
- | - | $ 218 M | Nasdaq Global Select Market | USA |
 |
Xeris Pharmaceuticals
XERS
|
$ 15.08 | 15.29 % | $ 2.42 B | Nasdaq Global Select Market | USA |
 |
X4 Pharmaceuticals
XFOR
|
$ 3.15 | 2.61 % | $ 133 M | Nasdaq Capital Market | USA |
 |
Entasis Therapeutics Holdings
ETTX
|
- | - | $ 105 M | Nasdaq Global Market | USA |
 |
Athersys
ATHX
|
- | 3.77 % | $ 22.4 M | Nasdaq Capital Market | USA |
 |
Zai Lab Limited
ZLAB
|
$ 25.49 | 12.77 % | $ 27.9 B | Nasdaq Global Select Market |  China |
 |
Zentalis Pharmaceuticals
ZNTL
|
$ 1.71 | 2.05 % | $ 123 M | Nasdaq Global Market | USA |
 |
Zoetis
ZTS
|
$ 79.51 | -3.21 % | $ 35.3 B | NYSE,SPB | USA |
 |
Global Blood Therapeutics
GBT
|
- | - | $ 4.62 B | Nasdaq Global Select Market,SPB | USA |
 |
Inozyme Pharma
INZY
|
- | - | $ 207 M | Nasdaq Global Select Market | USA |
 |
Idera Pharmaceuticals
IDRA
|
- | -23.04 % | $ 26.6 M | Nasdaq Global Select Market | USA |
 |
NanoString Technologies
NSTG
|
- | -37.43 % | $ 5.1 M | Nasdaq Global Select Market | USA |
 |
Humanigen
HGEN
|
- | -81.12 % | $ 4.28 M | Nasdaq Global Select Market | USA |
 |
Sorrento Therapeutics
SRNE
|
- | -29.58 % | $ 126 M | Nasdaq Global Select Market | USA |
 |
Surface Oncology
SURF
|
- | - | $ 59.7 M | Nasdaq Global Select Market | USA |
 |
GlaxoSmithKline plc
GSK
|
$ 50.28 | -0.27 % | $ 204 B | NYSE |  Britain |
 |
Sierra Oncology
SRRA
|
- | -0.05 % | $ 1.34 B | Nasdaq Global Select Market |  Canada |
 |
Cocrystal Pharma
COCP
|
$ 1.03 | 2.95 % | $ 11.6 M | Nasdaq Capital Market | USA |
 |
Atea Pharmaceuticals
AVIR
|
$ 4.27 | 1.18 % | $ 348 M | Nasdaq Global Select Market | USA |
 |
Vaccinex
VCNX
|
- | -61.37 % | $ 654 K | Nasdaq Global Select Market | USA |
 |
ImmuCell Corporation
ICCC
|
$ 9.9 | -0.5 % | $ 89.4 M | Nasdaq Global Select Market | USA |
 |
Nymox Pharmaceutical Corporation
NYMX
|
- | -19.68 % | $ 18.4 M | Nasdaq Capital Market | Canada |
 |
Akero Therapeutics
AKRO
|
- | - | $ 3.67 B | Nasdaq Global Select Market,SPB | USA |
 |
Jounce Therapeutics
JNCE
|
- | - | $ 98.4 M | Nasdaq Global Select Market | USA |
 |
Immutep Limited
IMMP
|
$ 3.25 | 20.82 % | $ 4.73 B | Nasdaq Global Market |  Australia |
 |
Verona Pharma plc
VRNA
|
- | - | $ 69.7 B | Nasdaq Global Select Market | Britain |
 |
Keros Therapeutics
KROS
|
$ 9.32 | -1.43 % | $ 347 M | Nasdaq Global Select Market | USA |
 |
Kazia Therapeutics Limited
KZIA
|
$ 7.19 | 2.71 % | $ 110 M | Nasdaq Global Select Market | Australia |
 |
Corner Growth Acquisition Corp.
COOL
|
- | -0.89 % | $ 114 M | Nasdaq Global Select Market | USA |
 |
Ligand Pharmaceuticals Incorporated
LGND
|
$ 306.2 | 2.41 % | $ 5.92 B | Nasdaq Global Select Market,SPB | USA |
 |
Acorda Therapeutics
ACOR
|
- | -24.86 % | $ 820 K | Nasdaq Global Select Market | USA |
 |
Ampio Pharmaceuticals
AMPE
|
- | -11.43 % | $ 502 K | NYSE American | USA |
 |
Akari Therapeutics, Plc
AKTX
|
$ 7.95 | 2.57 % | $ 535 B | Nasdaq Capital Market | Britain |
 |
Mersana Therapeutics
MRSN
|
- | - | $ 3.56 B | Nasdaq Global Select Market | USA |
 |
CymaBay Therapeutics
CBAY
|
- | - | $ 3.45 B | Nasdaq Global Select Market | USA |